Work

Heterogeneous CD52 Expression among Hematologic Neoplasms: Implications for the Use of Alemtuzumab (CAMPATH-1H)

Year: 2006

Type: article

Study design: Observational Study

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-06-1275

Authors: Scott J. Rodig, Jeremy S. Abramson, Geraldine S. Pinkus, Steven P. Treon, David M. Dorfman, Henry Y. Dong, Margaret A. Shipp, Jeffery L. Kutok

Institutions: Brigham and Women's Hospital, Dana-Farber Cancer Institute

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2140181964

FWCI: 7.329

Cites: 25

Cited by: 135

Related to: 10